Life Science White Papers

RSS

Life Science White Papers are in-depth articles aimed to educate and inform site visitors interested in life science research. Some of these papers are derived from sources where we have existing commercial relationships. Such articles are clearly labelled as sponsored content and are only accepted when the content is deemed to add value to the core editorial ethos of News Medical.

Microbial air monitoring in clean room environments: Methods and issues

In this article, Sartorius describes how to achieve continuous microbial air monitoring in clean room environments. They also discuss the issues, methods and ideas behind the process.

From Sartorius 30 Jun 2022

The best methods to avoid contamination in pipetting

In this guide, Sartorius gives a brief outline into pipette contamination and provides tips on how this can be best mitigated.

From Sartorius 30 Jun 2022

A practical guide to selecting a mechanical pipette

Pipette selection is crucial to a well-functioning experiment. This practical guide from Sartorius helps you decide the critical factors that come into play when selecting a mechanical pipette.

From Sartorius 30 Jun 2022

Why ultrapure water is critical for HPLC analysis

Solvent quality is crucial for reliable HPLC analysis. To this end, ultrapure water is often utilized. In this article, Sartorius describes their system of producing ultrapure water.

From Sartorius 30 Jun 2022

Manufacturing lentiviral vectors: How can this be optimized?

In this article, Jinwei Bio introduces their lentiviral manufacturing processes and discusses the various benefits this entails.

From Jinwei Bio 30 Jun 2022

An introduction to lentiviral vectors and their usage in the life sciences

In this article, Jinwei Bio discusses lentiviral vectors, providing a brief introduction into what they are and how they can be utilized within the life sciences.

From Jinwei Bio 30 Jun 2022

COVID-19: Omicron recombinants, where could the next strain emerge?

In this article, ACROBiosystems discusses COVID-19, specifically omicron recombinants and how this could lead to new, infectious strains emerging.

From Virus - An ACROBiosystems Brand 21 Jun 2022

The applications of respiratory syncytial virus antigens and antibodies in therapeutic and immunological development

Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections worldwide, recently there has been a surge in interest in RSV antigens, antibodies, and more in therapeutic and immunological development.

From Sino Biological Inc. 31 May 2022

Reviewing immunological breast cancer targets

In this article, ACROBiosystems review some major and minor immunological breast cancer targets. they divide the therapies into three categories and elaborate upon each one.

From ACROBiosystems 30 May 2022

Therapeutic strategies for brain tumors: An overview

Brain tumors cause 29.5% of cancer-related deaths. In this overview, three potential strategies, a classical, potential, and innovative strategy are introduced and their ability to treat a brain tumor is discussed.

From Aneuro - An ACROBiosystems Brand 30 May 2022

Targeting DLL-3 for a variety of potential lung cancer therapies

In this article, ACROBiosystems demonstrates how DLL-3 could become a potential target for a variety of lung cancer therapies.

From ACROBiosystems 30 May 2022

Multiple Sclerosis: Examining the pathology, etiology, and potential therapeutic drugs

In this article, ACROBiosystems discusses Multiple Sclerosis, examining the pathology, etiology, and an array of potential therapeutic drugs.

From Aneuro - An ACROBiosystems Brand 30 May 2022

Developments in the targeting of Claudin 6 in Antibody and CAR-T cell therapies

Claudin 6 is an intercellular molecule that plays a vital role in the formation of tight junctions in cells. Found to be overexpressed in a variety of solid tumors, it has now emerged as a potential target for Antibody (mAb, bsAb, ADC) and CAR-T cell therapy.

From FLAG - An ACROBiosystems Brand 30 May 2022

Discussing major hypotheses of Alzheimer’s disease

In this article, ACROBiosystems discusses three major hypotheses of Alzheimer’s disease and elucidates on the viability of each one.

From Aneuro - An ACROBiosystems Brand 30 May 2022

Combating Parkinson’s disease, the second most common neurodegenerative disease

Parkinson’s disease is the second most common neurodegenerative disease. As it continues to affect more and more people, there’s massive demand for continued and new research into novel and efficacious treatments for the condition.

From Aneuro - An ACROBiosystems Brand 30 May 2022

Examining the potential of CXCR4 and CCR5 as therapeutic targets for cancer and HIV therapy

The CXCR4 and CCR5 receptors have been emerging as potentially effective therapeutic targets for Cancer and HIV therapy. This article discusses their potential efficacy.

From FLAG - An ACROBiosystems Brand 30 May 2022

The pathology and epidemiology of Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder that is highly lethal. In this article, ACROBiosystems discusses the pathology, epidemiology, pathogenesis, and potential drug targets for the condition.

From Aneuro - An ACROBiosystems Brand 30 May 2022

IFN-γ: Targeted antibodies for detection and monitoring

IFN-γ is a multi-effect cytokine that plays a huge role in the congenital and adaptive immune reactions. As such, the monitoring and detection of IFN-γ is very important in clinical research. To this end, ACROBiosystems have produced a range of anti-IFN-γ antibodies.

From ClinMax - An ACROBiosystems Brand 30 May 2022

Detecting Anti-SARS-CoV-2 antibodies through the use of flow cytometry

In this article, Sartorius discusses how advanced flow cytometry can be used for the detection of anti-SARS-CoV-2 antibodies, including IgG, IgM and IgA and how Sartorius can provide a robust and sensitive serological assay.

From Sartorius 20 May 2022

Expressing recombinant proteins with a baculovirus-insect cell system

In this article, Sino Biological discusses how they express recombinant proteins with their baculovirus-insect cell system. They elaborate on the processes, challenges and high quality nature of their system.

9 May 2022